SEC filings · ABBV
AbbVie SEC filings
Every annual report, quarterly report, proxy statement and current report AbbVie has filed with the SEC since 2025, each linked to the original on SEC EDGAR. Filing.fyi links to the SEC; it does not host copies.
Annual reports (10-K)
- Feb 20, 202610-KAnnual report Period ended Dec 31, 2025
Quarterly reports (10-Q)
- Aug 3, 202610-QQuarterly report Period ended Jun 30, 2026
- Nov 4, 202510-QQuarterly report Period ended Sep 30, 2025
Proxy statements (DEF 14A)
- Mar 23, 2026DEF 14AProxy statement
- Mar 24, 2025DEF 14AProxy statement
Current reports (8-K)
- Oct 15, 20268-KCurrent report: Departure/appointment of officers or directors
- Oct 5, 20268-KCurrent report
- Sep 3, 20268-KCurrent report
- Aug 18, 20268-KCurrent report
- Aug 5, 20268-KCurrent report
- Jul 31, 20268-KCurrent report
- Apr 3, 20268-KCurrent report
- Mar 4, 20268-KCurrent report
- Feb 26, 20268-KCurrent report Event date Feb 24, 2026
- Feb 4, 20268-KCurrent report
- Jan 7, 20268-KCurrent report
- Oct 31, 20258-KCurrent report
Insider transactions (Form 4)
- Oct 2, 2026Form 4Insider transaction
- Oct 2, 2026Form 4Insider transaction
- Aug 18, 2026Form 4Insider transaction
Registrations and other filings
- Aug 4, 2026424B5424B5
Source: SEC EDGAR. Open ABBV on EDGAR →